Skip to main content

Mono Bar

Main Menu

Subsite Title

Publications and Digital Products

Cart

Store Navigation

Share Buttons

Page title

Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs

Main page content

KAP Keys for Clinicians Based on TIP 43
Download only

This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women.

Publication ID
SMA12-4108
Publication Date
January 2012

You May Also Be Interested In

Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders

This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances.

A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders

This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment.

TIP 63: Medications for Opioid Use Disorder - Full Document

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

TIP 63: Medications for Opioid Use Disorder - Executive Summary

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.